Kopra Bio (YC Summer 2024)

TL;DR: Kopra Bio is a Y Combinator Summer 2024 startup Genetically engineered viruses that teach your immune system to kill…, currently active with a team of 2.

Genetically engineered viruses that teach your immune system to kill…

YC ID
29714
YC Batch
Summer 2024
Status
Active
Team size
2
Industry
Healthcare, Therapeutics
Tags
Gene Therapy, Synthetic Biology, Biotech
YC profile
https://www.ycombinator.com/companies/kopra-bio

Last verified:

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is Kopra Bio a YC (Y Combinator) company?

Yes. Kopra Bio was funded by Y Combinator in the Summer 2024 batch. Genetically engineered viruses that teach your immune system to kill…

What does Kopra Bio do?

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve surv…

What YC batch was Kopra Bio in?

Kopra Bio was part of Y Combinator's Summer 2024 batch.

How big is Kopra Bio?

Kopra Bio has a team of 2 people according to Y Combinator's directory.

Is Kopra Bio still active?

Kopra Bio is currently listed as Active with a team of 2 in Y Combinator's directory.

More YC Summer 2024 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…